Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Pulmonary Arterial Equipment Supplied In Europe
12 equipment items found
Manufactured by:Endotronix, Inc. based inLisle, ILLINOIS (USA)
Introducing the Cordelia® System, a solution that helps you achieve guideline-directed medical therapy with your patients using a streamlined workflow. Along with regular clinic visits, the system uses an intuitive Patient Management Portal and an at-home patient kit to improve outcomes and proactively treat more ...
Manufactured by:Sahajanand Medical Technologies Ltd. based inSurat, INDIA
Hat-shaped design ensures secured implantation at the aorta and minimizes risk of migration into pulmonary artery. Unique Platinum coating. Device is filled with polypropylene fabric to assist thrombogenicity. Extended retention portion provides proper positioning of the device in the ductus arteriosus. 100% occlusion rate at one-month follow-up. ...
Manufactured by:Artivion, Inc based inKennesaw, GEORGIA (US) (USA)
Femoral Vein vs. PTFE Graft: Stage I Norwood1. For patients receiving a Femoral Vein: Better growth and development of branch pulmonary arteries. Improved Nakata Index. No recognizable adverse events with ...
by:tiakis BIOTECH AG based inKiel, GERMANY
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the prevention of postoperative inflammatory ...
Manufactured by:Artivion, Inc based inKennesaw, GEORGIA (US) (USA)
The Ideal Patch for: Congenital reconstructions. Repair of the RVOT. ...
Manufactured by:Lonza Group Ltd based inBasel, SWITZERLAND
Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 SingleQuotsTM Supplements (CC-4176) required for growth of Endothelial Cells. Available for immediate ...
Manufactured by:Lonza Group Ltd based inBasel, SWITZERLAND
Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 MV Microvascular Endothelial Cell Growth Medium SingleQuotsTM supplements (CC-4147) required for growth of Microvascular Endothelial ...
Manufactured by:Artivion, Inc based inKennesaw, GEORGIA (US) (USA)
Applications - Tissue: Descending Thoracic Aorta. Size: Diameter = 14mm (min.). Catalog Number: A0203. Additional CryoGraft Tissue. Ideal for: Conduit repair, Aortic graft infections, Aneurysm ...
Manufactured by:Osypka AG based inRheinfelden, GERMANY
The VACS dilatation catheter is a PTV Balloon Catheter with a coaxial shaft construction and a non-compliant balloon which can easily be placed over a guide wire. The low balloon profi le of the VACS® II balloon catheter allows the use of smallest introducers. The VACS III is a particularly high pressure balloon catheter due to a reinforced balloon ...
Manufactured by:Medtronic based inMinneapolis, MINNESOTA (USA)
The Crescent™* catheter is the first FDA-cleared, jugular dual lumen long-term ECMO catheter. It allows for more accurate placement with just one cannulation site, delivers enhanced flow dynamics, and helps maintain optimal flow† once placed. ...
Manufactured by:Gesynta Pharma AB based inStockholm, SWEDEN
Microsomal prostaglandin E synthase (mPGES-1) is an enzyme generally present at low levels in the human body. It stimulates production of prostaglandin E2 (PGE2), a potent biological messenger that has a pronounced impact on inflammation. During inflammation the levels of mPGES-1 are upregulated, causing excessive levels of PGE2, which drive the inflammatory symptoms. ...
Manufactured by:Carmat based inImmeuble l’Etendard, FRANCE
Carmat aims to meet a major public health challenge related to cardiovascular diseases, namely heart failure, the leading cause of death in the western world. More specifically, Carmat aims to provide a lasting solution for the treatment of terminal heart failure, a disease for which there are very few effective options today, the main one being heart ...